Enterprise Profile

Revenue in millions of dollars

BD Medical is among the world’s leading suppliers of medical devices. BD built the first-ever manufacturing facility in the U.S. to produce syringes and needles in 1906 and has been the leading innovator in injection- and infusion-based drug delivery ever since.

Principal product lines include needles, syringes and intravenous catheters for medication delivery; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; surgical blades and regional anesthesia needles; critical care monitoring devices; ophthalmic surgical instruments; sharps disposal containers; and home healthcare products such as ACE brand elastic bandages.
      BD Medical’s business strategy is focused on effectively addressing four global health needs:
     Reducing the spread of infection...with an extensive line of safety-engineered devices to reduce the risk of sharps injuries to healthcare workers around the world–a field in which BD is a global leader. BD Medical provides innovative IV flush syringes and closed IV catheter systems that are designed to enhance patient safety by reducing the potential for medical errors and device contamination while promoting healthcare worker safety.BD Medical also offers low cost, auto-disabling injection devices for immunization and parenteral therapies, intended to prevent disease spread associated with syringe reuse in developing countries.
     Enhancing diabetes treatment...with devices for insulin injection and educational programs to promote wellness and intensive diabetes management. BD developed the first syringe dedicated to insulin delivery in 1924 and has made continuous advances ever since. Today’s insulin injection needles are tiny and virtually pain-free, and insulin injection offers precise dose control leading to tighter control of blood glucose levels. BD is investing to increase insulin pen needle manufacturing capacity based on rapid expansion in global diabetes prevalence and expanding application of these products for insulin and noninsulin diabetes treatment. BD is committed to addressing the needs of people with diabetes worldwide.
     Advancing drug delivery...the category leader in prefillable devices, BD works with more than 100 pharmaceutical companies. Injectable drugs sold in prefilled syringe formats reduce the potential for medication error and contamination while providing drug companies with a means to differentiate their offering. For future implementation, BD is developing an advanced “Micro-Delivery” platform for injection of vaccines that may offer important therapeutic advantages versus conventional injection methods.
     Improving ophthalmic surgery outcomes...through new technologies that enhance blade sharpness while protecting ophthalmic surgeons and their staffs from occupational injury. BD offers cataract blades and cannulae, as well as other ophthalmic surgical accessories. Strategic investments in innovative solutions to other ophthalmic medical needs hold the potential for future growth in this field.

BD PosiFlush Saline and Heparin Lock Flush Syringes help protect patients and clinicians alike by eliminating needles. These devices are manufactured by BD using an automated process. The child-friendly Musical SpongeBob™ digital thermometer delivers a reading in just nine seconds, features a lighted display and enhances temperature taking with the SpongeBob™ SquarePants™ musical theme. The BD Bard-Parker Protected Disposable Scalpel is available in a complete range of blade sizes and designed for simple one-handed activation. The safety-engineered shield is designed to lock securely to provide protection before and after use. BD offers a wide range of standard and custom regional anesthesia trays for spinal, epidural, combined spinal and epidural, peripheral block and pain management procedures.